Nicolas Hohmann
0000-0001-8036-8806
1 paper found
Refreshing results…
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer
Missing publications? Search for publications with a matching author name.